尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the complete record of transactions filed by Manhard Kimberly, Directeur Exécutif. Officer active across 3 companies, notably Heron Therapeutics, INC.. In total, 13 disclosures have been recorded. Breakdown: 1 buy · 2 sells. Total volume traded: €225k. History available since 30 April 2021. The latest transaction was filed on 8 September 2026 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
13 条申报中的 13 条
MANHARD KIMBERLY is a Director Exécutif and is linked to Heron Therapeutics, INC., HERON THERAPEUTICS, INC. /DE/, and Inhibrx Biosciences, Inc. She has 11 filings in total. Across the 11 sampled recent filings, the most frequent transaction nature is Levée d'options, with EUR 125663 of buys and EUR 0 of sells between 2021-05-04 and 2024-08-30.